Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
607
-
Total 13F shares, excl. options
-
54,006,104
-
Shares change
-
-190,630
-
Total reported value, excl. options
-
$5,764,090,120
-
Value change
-
-$20,390,359
-
Put/Call ratio
-
174%
-
Number of buys
-
260
-
Number of sells
-
303
-
Price
-
$106.74
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2018
As of 31 Mar 2018 ISHARES TR - ISHARES BIOTECH (IBB) had 760 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 54,006,104 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, DEUTSCHE BANK AG\, MORGAN STANLEY, UBS Group AG, CITIGROUP INC, GOLDMAN SACHS GROUP INC, BNP PARIBAS ARBITRAGE, SA, NATIXIS, ROYAL BANK OF CANADA, and WELLS FARGO & COMPANY/MN.
This table shows 760 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.